oxis turbuhaler 12 mikrog/annos inhalaatiojauhe
astrazeneca oy - formoterol fumarate dihydrate - inhalaatiojauhe - 12 mikrog/annos - formoteroli
fomeda easyhaler 12 mikrog/annos inhalaatiojauhe
orion corporation - formoterol fumarate dihydrate - inhalaatiojauhe - 12 mikrog/annos - formoteroli
innovair nexthaler 200 mikrog / 6 mikrog / inhalaatio inhalaatiojauhe
chiesi farmaceutici spa - formoterol fumarate dihydrate, beclometasone dipropionate anhydrate - inhalaatiojauhe - 200 mikrog / 6 mikrog / inhalaatio - formoteroli ja beklometasoni
innovair 200 / 6 mikrog / annos inhalaatiosumute, liuos
chiesi farmaceutici spa - formoterol fumarate dihydrate, beclometasone dipropionate anhydrate - inhalaatiosumute, liuos - 200 / 6 mikrog / annos - formoteroli ja beklometasoni
aforbe 100 / 6 mikrog / annos inhalaatiosumute, liuos
viatris limited - formoterol fumarate dihydrate, beclometasone dipropionate - inhalaatiosumute, liuos - 100 / 6 mikrog / annos - formoteroli ja beklometasoni
symbicort turbuhaler mite inhalaatiojauhe
astrazeneca oy - budesonide, formoterol fumarate dihydrate - inhalaatiojauhe - formoteroli ja budesonidi
bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - keuhkosairaus, krooninen obstruktiivinen - formoteroli ja glykopyrroniumbromidi - bevespi aerosphere on merkitty huolto keuhkoputkia hoito lievittää oireita aikuisilla potilailla, joilla on krooninen keuhkoahtaumatauti (copd).
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
formoterol hexal 12 mikrog inhalaatiojauhe, kapseli, kova
hexal ag - formoteroli fumaras - inhalaatiojauhe, kapseli, kova - 12 mikrog - formoteroli